Praeventix
PrivateLast Round
Seed Round
Sep 10, 2026
Total Funding Raised
$7.2M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Praeventix is a biotechnology company that develops novel serotonergic therapeutics and signal transduction-modulating agents for the treatment of inflammatory, dermatologic, and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Praeventix Comparables
Compare Praeventix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alys Pharmaceuticals | 72% | |
| Attovia Therapeutics | 67% | |
| Evommune | 67% |
Praeventix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Sep 10, 2026 | ||||
| Series A | Feb 13, 2026 | ||||
| Seed | Nov 8, 2022 |
Praeventix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| Tellus BioVentures | Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 10, 2026
Raised $5.6M in a Seed Round.
- Feb 13, 2026
Completed a Series A funding round.
Praeventix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Praeventix's valuation, stock price, and market status.
Is Praeventix a public or private company?
Praeventix is a private company.
What is the current stock price of Praeventix?
Praeventix is a private company with no public stock price. No recent secondary market data is available.
How much is Praeventix worth (valuation)?
Valuation information for Praeventix is not publicly available.
Can I buy Praeventix stock?
Praeventix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Praeventix's last funding round?
Praeventix's most recent funding round was Series A on February 13, 2026.
Who are the main investors in Praeventix?
Key investors in Praeventix include National Institute on Drug Abuse, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Tellus BioVentures, National Institute of Diabetes and Digestive and Kidney Diseases.
Will Praeventix IPO soon?
No public IPO plans have been announced for Praeventix.
How can I track Praeventix secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Praeventix's secondary market activity and sign up for updates.